MarketPeel
Insider Trading Intelligence
AH

Anthony Hunt

BLFS
DIRECTOR · BIOLIFE SOLUTIONS INC · CIK 0001606030
FILING MIX · LIFETIME29%/71%
BUYS
65
SELLS
157
TOTAL VALUE
$115.64M
COMPANIES
3
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
110,317
AVG SELL PX
$167.98
TRADE KIND
SHOWING 222 / 222
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
114 backtested trades · 8 horizons · 52 pending
Forward-return performance of every backtestable P/S trade by Anthony Hunt, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d114+53.51%-0.20%+0.00%-0.20%-0.51%-0.40
14d114+50.00%-0.56%-0.41%-0.15%-1.08%-0.16
30d114+46.49%-0.58%-0.33%-0.25%-0.02%-0.20
60d114+53.51%+0.44%+3.12%-2.67%-7.38%-1.44
90d114+61.40%+2.11%+5.18%-3.07%-10.38%-1.34
180d114+55.26%+6.19%+9.64%-3.45%-9.97%-1.13
1y114(18 pending)+78.13%+4.33%+14.07%-9.74%-22.24%-2.18
2y114(34 pending)+68.75%-3.53%+22.14%-25.67%-22.95%-5.10
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
BLFS · 15,046 shares · as of Feb 24, 2026
03,7627,52311,28515,0462026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 65 buys / 157 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
MASS
908 DEVICES INC.
PURCHASEGRANT
Stock grant
6,2096,209Jun 11, 2026Jun 12, 2026View →
MASS
908 DEVICES INC.
PURCHASEGRANT
Stock grant
13,65613,656Jun 11, 2026Jun 12, 2026View →
MASS
908 DEVICES INC.
PURCHASE
14,08344,168Jun 10, 2026Jun 12, 2026View →
MASS
908 DEVICES INC.
SALE
14,0830Jun 10, 2026Jun 12, 2026View →
RGEN
REPLIGEN CORP
SALE
9,897$124.97$1.24M89,062Mar 2, 2026Mar 3, 2026View →
BLFS
BIOLIFE SOLUTIONS INC
PURCHASEGRANT
Stock grant
8,17015,046Feb 24, 2026Feb 26, 2026View →
RGEN
REPLIGEN CORP
SALE
2,00098,959Dec 4, 2025Dec 8, 2025View →
RGEN
REPLIGEN CORP
PURCHASE
2,952$33.87$100.0K83,695Nov 13, 2025Nov 14, 2025View →
RGEN
REPLIGEN CORP
SALE
2,923$153.14$447.6K93,936Nov 13, 2025Nov 14, 2025View →
RGEN
REPLIGEN CORP
SALE
1,956$157.11$307.3K80,743Nov 13, 2025Nov 14, 2025View →
RGEN
REPLIGEN CORP
SALE
5,737$156.22$896.2K82,699Nov 13, 2025Nov 14, 2025View →
RGEN
REPLIGEN CORP
SALE
1,784$151.01$269.4K98,959Nov 13, 2025Nov 14, 2025View →
RGEN
REPLIGEN CORP
SALE
2,500$154.32$385.8K91,436Nov 13, 2025Nov 14, 2025View →
RGEN
REPLIGEN CORP
SALE
3,000$155.45$466.4K88,436Nov 13, 2025Nov 14, 2025View →
RGEN
REPLIGEN CORP
SALE
2,100$152.17$319.6K96,859Nov 13, 2025Nov 14, 2025View →
RGEN
REPLIGEN CORP
PURCHASE
2,95214,760Nov 13, 2025Nov 14, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
3,741$154.92$579.6K122,002Nov 12, 2025Nov 13, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
464$158.51$73.5K100,743Nov 12, 2025Nov 13, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
4,959$156.65$776.8K112,303Nov 12, 2025Nov 13, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
4,740$155.85$738.7K117,262Nov 12, 2025Nov 13, 2025View →
RGEN
REPLIGEN CORP
SALE
25,000157,344Nov 12, 2025Nov 13, 2025View →
RGEN
REPLIGEN CORP
PURCHASE
25,000$33.87$846.8K125,743Nov 12, 2025Nov 13, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
11,096$158.01$1.75M101,207Nov 12, 2025Nov 13, 2025View →
RGEN
REPLIGEN CORP
SALE
7,584$121.42$920.8K102,922Sep 10, 2025Sep 11, 2025View →
RGEN
REPLIGEN CORP
SALE
20,000182,344Sep 10, 2025Sep 11, 2025View →
RGEN
REPLIGEN CORP
SALE
2,179$122.23$266.3K100,743Sep 10, 2025Sep 11, 2025View →
RGEN
REPLIGEN CORP
SALE
14,882$120.19$1.79M110,506Sep 10, 2025Sep 11, 2025View →
RGEN
REPLIGEN CORP
PURCHASE
20,000$33.87$677.4K129,854Sep 10, 2025Sep 11, 2025View →
RGEN
REPLIGEN CORP
SALE
1,108$118.32$131.1K128,650Sep 10, 2025Sep 11, 2025View →
RGEN
REPLIGEN CORP
SALE
96$116.34$11.2K129,758Sep 10, 2025Sep 11, 2025View →
RGEN
REPLIGEN CORP
SALE
3,262$119.64$390.3K125,388Sep 10, 2025Sep 11, 2025View →
MASS
908 DEVICES INC.
PURCHASEGRANT
Stock grant
6,5166,516Jun 12, 2025Jun 13, 2025View →
MASS
908 DEVICES INC.
PURCHASEGRANT
Stock grant
14,08314,083Jun 12, 2025Jun 13, 2025View →
MASS
908 DEVICES INC.
SALE
11,3640Jun 11, 2025Jun 13, 2025View →
MASS
908 DEVICES INC.
PURCHASE
11,36430,085Jun 11, 2025Jun 13, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
268$125.20$33.6K109,861May 15, 2025May 16, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
17,596$123.57$2.17M116,662May 15, 2025May 16, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
2,043$122.66$250.6K134,258May 15, 2025May 16, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
7$127.00$889109,854May 15, 2025May 16, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
6,533$124.34$812.3K110,129May 15, 2025May 16, 2025View →
BLFS
BIOLIFE SOLUTIONS INC
PURCHASEGRANT
Stock grant
6,8766,876Mar 18, 2025Mar 20, 2025View →
RGEN
REPLIGEN CORP
PURCHASE
5,000$33.87$169.3K141,301Mar 17, 2025Mar 19, 2025View →
RGEN
REPLIGEN CORP
SALE
21,7560Mar 17, 2025Mar 19, 2025View →
RGEN
REPLIGEN CORP
SALE
5,000202,344Mar 17, 2025Mar 19, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
100$150.38$15.0K162,897Mar 17, 2025Mar 19, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
15,619$152.82$2.39M138,584Mar 17, 2025Mar 19, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
60$148.05$8.9K162,997Mar 17, 2025Mar 19, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
6,176$151.96$938.5K154,203Mar 17, 2025Mar 19, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
2,283$153.70$350.9K136,301Mar 17, 2025Mar 19, 2025View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
2,518$151.09$380.4K160,379Mar 17, 2025Mar 19, 2025View →
RGEN
REPLIGEN CORP
PURCHASE
21,756$59.52$1.29M163,057Mar 17, 2025Mar 19, 2025View →
RGEN
REPLIGEN CORP
SALE
10,142$155.38$1.58M136,301Mar 3, 2025Mar 4, 2025View →
MASS
908 DEVICES INC.
SALE
2,0580Mar 2, 2025Mar 4, 2025View →
MASS
908 DEVICES INC.
PURCHASE
2,05818,721Mar 2, 2025Mar 4, 2025View →
RGEN
REPLIGEN CORP
SALE
2,825$156.54$442.2K146,443Feb 27, 2025Feb 28, 2025View →
RGEN
REPLIGEN CORP
SALE
2,380$164.74$392.1K149,268Feb 24, 2025Feb 25, 2025View →
RGEN
REPLIGEN CORP
PURCHASE
11,8088,856Dec 5, 2024Dec 5, 2024View →
RGEN
REPLIGEN CORP
PURCHASE
11,808$33.87$399.9K151,648Dec 5, 2024Dec 5, 2024View →
RGEN
REPLIGEN CORP
SALE
24,246$139.67$3.39M139,840Nov 21, 2024Nov 22, 2024View →
RGEN
REPLIGEN CORP
PURCHASE
24,2460Nov 21, 2024Nov 22, 2024View →
RGEN
REPLIGEN CORP
PURCHASE
24,246$33.87$821.2K164,086Nov 21, 2024Nov 22, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
604$146.67$88.6K139,840Sep 10, 2024Sep 12, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
1,495$143.77$214.9K160,536Sep 10, 2024Sep 12, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
10,723$145.95$1.57M140,444Sep 10, 2024Sep 12, 2024View →
RGEN
REPLIGEN CORP
PURCHASE
10,000$33.87$338.7K162,031Sep 10, 2024Sep 12, 2024View →
RGEN
REPLIGEN CORP
PURCHASE
10,00024,246Sep 10, 2024Sep 12, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
9,369$144.88$1.36M151,167Sep 10, 2024Sep 12, 2024View →
RGEN
REPLIGEN CORP
SALE
13,146152,031Sep 3, 2024Sep 4, 2024View →
RGEN
REPLIGEN CORP
SALE
13,0576,528Sep 3, 2024Sep 4, 2024View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
2,000$124.08$248.2K165,177Jun 14, 2024Jun 14, 2024View →
MASS
908 DEVICES INC.
PURCHASEGRANT
Stock grant
15,99615,996Jun 13, 2024Jun 14, 2024View →
MASS
908 DEVICES INC.
PURCHASEGRANT
Stock grant
11,36411,364Jun 13, 2024Jun 14, 2024View →
MASS
908 DEVICES INC.
SALE
7,7770Jun 12, 2024Jun 14, 2024View →
MASS
908 DEVICES INC.
PURCHASE
7,77716,663Jun 12, 2024Jun 14, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
4,274$166.36$711.0K178,975May 21, 2024May 22, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
4,008$167.05$669.5K174,967May 21, 2024May 22, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
3,925$170.04$667.4K164,146May 21, 2024May 22, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
3,933$168.33$662.0K171,034May 21, 2024May 22, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
969$171.03$165.7K163,177May 21, 2024May 22, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
2,963$169.27$501.5K168,071May 21, 2024May 22, 2024View →
RGEN
REPLIGEN CORP
SALEGRANT
Gift
2,000183,249Mar 18, 2024Mar 20, 2024View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
1$16.55$17201,956Mar 8, 2024Mar 11, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
1,666$197.39$328.9K190,685Mar 8, 2024Mar 11, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
6,228$196.32$1.22M192,351Mar 8, 2024Mar 11, 2024View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
10Mar 8, 2024Mar 11, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
1,822$199.53$363.5K187,516Mar 8, 2024Mar 11, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
3,377$195.49$660.2K198,579Mar 8, 2024Mar 11, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
1,305$200.56$261.7K186,211Mar 8, 2024Mar 11, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
156$202.55$31.6K185,249Mar 8, 2024Mar 11, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
806$201.75$162.6K185,405Mar 8, 2024Mar 11, 2024View →
RGEN
REPLIGEN CORP
SALE10b5-1
10b5-1 plan
1,347$198.55$267.4K189,338Mar 8, 2024Mar 11, 2024View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
2,867$195.72$561.1K201,955Mar 7, 2024Mar 7, 2024View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
7,275$195.52$1.42M204,822Mar 5, 2024Mar 6, 2024View →
MASS
908 DEVICES INC.
SALE
2,0572,058Mar 4, 2024Mar 5, 2024View →
MASS
908 DEVICES INC.
PURCHASE
2,0578,886Mar 4, 2024Mar 5, 2024View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,111$193.99$215.5K212,097Mar 4, 2024Mar 6, 2024View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
3,322$191.79$637.1K213,208Mar 1, 2024Mar 4, 2024View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
2,504216,530Feb 29, 2024Mar 4, 2024View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
19,719214,026Feb 27, 2024Feb 29, 2024View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
19,58519,585Feb 27, 2024Feb 29, 2024View →
RGEN
REPLIGEN CORP
SALEGRANT
Gift
1,000194,307Nov 14, 2023Nov 16, 2023View →
MASS
908 DEVICES INC.
PURCHASEGRANT
Stock grant
12,07612,076Jun 15, 2023Jun 16, 2023View →
MASS
908 DEVICES INC.
PURCHASEGRANT
Stock grant
7,7777,777Jun 15, 2023Jun 16, 2023View →
MASS
908 DEVICES INC.
PURCHASE
4,7716,829Jun 14, 2023Jun 16, 2023View →
MASS
908 DEVICES INC.
SALE
4,7710Jun 14, 2023Jun 16, 2023View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
18,584203,551Mar 3, 2023Mar 6, 2023View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
8,244$188.00$1.55M195,307Mar 3, 2023Mar 6, 2023View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
6,670$176.37$1.18M165,574Mar 2, 2023Mar 2, 2023View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
19,393184,967Mar 2, 2023Mar 6, 2023View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
20,08020,080Mar 2, 2023Mar 6, 2023View →
MASS
908 DEVICES INC.
PURCHASE
2,0582,058Mar 2, 2023Mar 7, 2023View →
MASS
908 DEVICES INC.
SALE
2,0584,115Mar 2, 2023Mar 7, 2023View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
3,273$173.44$567.7K174,992Feb 28, 2023Feb 28, 2023View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
2,748$173.28$476.2K172,244Feb 28, 2023Mar 2, 2023View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
25,000$200.00$5.00M178,265Nov 11, 2022Nov 14, 2022View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
25,00034,246Nov 11, 2022Nov 14, 2022View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
25,000$33.87$846.8K203,265Nov 11, 2022Nov 14, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
824$220.08$181.3K203,843Sep 8, 2022Sep 9, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,235$221.46$273.5K202,608Sep 8, 2022Sep 9, 2022View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
10,00059,246Sep 8, 2022Sep 9, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
6,626$224.47$1.49M193,873Sep 8, 2022Sep 9, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
720$222.24$160.0K201,888Sep 8, 2022Sep 9, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
245$227.01$55.6K178,265Sep 8, 2022Sep 9, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
10,490$225.22$2.36M183,383Sep 8, 2022Sep 9, 2022View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
10,000$33.87$338.7K204,667Sep 8, 2022Sep 9, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
4,873$226.34$1.10M178,510Sep 8, 2022Sep 9, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,389$223.26$310.1K200,499Sep 8, 2022Sep 9, 2022View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
5,00069,246Jul 21, 2022Jul 22, 2022View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
15,154$32.40$491.0K219,469Jul 21, 2022Jul 22, 2022View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
15,1540Jul 21, 2022Jul 22, 2022View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
5,000$33.87$169.3K204,315Jul 21, 2022Jul 22, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
24,802$200.00$4.96M194,667Jul 21, 2022Jul 22, 2022View →
MASS
908 DEVICES INC.
PURCHASEGRANT
Stock grant
7,9707,970Jun 16, 2022Jun 17, 2022View →
MASS
908 DEVICES INC.
PURCHASEGRANT
Stock grant
4,7714,771Jun 16, 2022Jun 17, 2022View →
MASS
908 DEVICES INC.
PURCHASEGRANT
Stock grant
10,36210,362Mar 2, 2022Mar 4, 2022View →
MASS
908 DEVICES INC.
PURCHASEGRANT
Stock grant
6,1736,173Mar 2, 2022Mar 4, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
7,292$194.06$1.42M199,315Mar 1, 2022Mar 3, 2022View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
30,074219,975Feb 28, 2022Mar 2, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
13,368$196.70$2.63M206,607Feb 28, 2022Mar 2, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
3,170$196.70$623.5K189,901Feb 28, 2022Mar 2, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
2,754$196.70$541.7K193,071Feb 27, 2022Mar 2, 2022View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
20,30720,307Feb 24, 2022Feb 28, 2022View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
15,855196,995Feb 24, 2022Feb 28, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,170$189.21$221.4K195,825Feb 24, 2022Feb 28, 2022View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
6,024$278.08$1.68M183,706Nov 18, 2021Nov 19, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
10,000$32.40$324.0K199,495Nov 18, 2021Nov 19, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,955$274.83$537.3K195,479Nov 18, 2021Nov 19, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,732$277.01$479.8K189,730Nov 18, 2021Nov 19, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
596$281.40$167.7K182,140Nov 18, 2021Nov 19, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
970$279.08$270.7K182,736Nov 18, 2021Nov 19, 2021View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
10,00015,154Nov 18, 2021Nov 19, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
2,061$273.91$564.5K197,434Nov 18, 2021Nov 19, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
4,017$276.20$1.11M191,462Nov 18, 2021Nov 19, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
14,825$294.90$4.37M191,134Sep 9, 2021Sep 13, 2021View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
25,000$32.40$810.0K214,495Sep 9, 2021Sep 13, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,631$296.09$482.9K189,503Sep 9, 2021Sep 13, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
8$296.58$2.4K189,495Sep 9, 2021Sep 13, 2021View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
25,00025,154Sep 9, 2021Sep 13, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
8,536$294.22$2.51M205,959Sep 9, 2021Sep 13, 2021View →
RGEN
REPLIGEN CORP
SALEGRANT
Gift
1,000189,495Aug 17, 2021Aug 18, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
7,911$170.28$1.35M201,710May 19, 2021May 20, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
3,036$172.52$523.8K195,254May 19, 2021May 20, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
612$168.29$103.0K212,150May 19, 2021May 20, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
3,420$171.32$585.9K198,290May 19, 2021May 20, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
380$175.15$66.6K190,495May 19, 2021May 20, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
2,529$169.45$428.5K209,621May 19, 2021May 20, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
2,819$174.41$491.7K190,875May 19, 2021May 20, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,560$173.19$270.2K193,694May 19, 2021May 20, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,171$188.77$221.0K219,779Mar 12, 2021Mar 12, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,378$192.17$264.8K213,224Mar 12, 2021Mar 12, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
235$194.08$45.6K212,762Mar 12, 2021Mar 12, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
227$193.30$43.9K212,997Mar 12, 2021Mar 12, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
914$188.06$171.9K220,950Mar 12, 2021Mar 12, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
4,096$190.17$778.9K215,683Mar 12, 2021Mar 12, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,081$191.19$206.7K214,602Mar 12, 2021Mar 12, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
4,271$186.90$798.2K228,243Mar 4, 2021Mar 8, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,633$185.22$302.5K221,864Mar 4, 2021Mar 8, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
6,193$193.45$1.20M233,109Mar 4, 2021Mar 8, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
4,746$185.91$882.3K223,497Mar 4, 2021Mar 8, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
461$196.44$90.6K242,509Mar 4, 2021Mar 8, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
2,125$194.43$413.2K239,302Mar 4, 2021Mar 8, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
595$187.48$111.6K232,514Mar 4, 2021Mar 8, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
794$197.94$157.2K242,970Mar 4, 2021Mar 8, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,082$195.54$211.6K241,427Mar 4, 2021Mar 8, 2021View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
10,437243,764Feb 24, 2021Feb 26, 2021View →
RGEN
REPLIGEN CORP
SALEGRANT
Stock grant
12,60112,601Feb 24, 2021Feb 26, 2021View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
20,0000Nov 19, 2020Nov 23, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
6,823$185.67$1.27M241,057Nov 19, 2020Nov 23, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
6,300$186.50$1.17M234,757Nov 19, 2020Nov 23, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
5,447$184.69$1.01M247,880Nov 19, 2020Nov 23, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,430$187.60$268.3K233,327Nov 19, 2020Nov 23, 2020View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
20,000$26.05$521.0K253,327Nov 19, 2020Nov 23, 2020View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
45,351$26.05$1.18M278,678Sep 10, 2020Sep 12, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
2,397$149.30$357.9K233,327Sep 10, 2020Sep 12, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
45,35120,000Sep 10, 2020Sep 12, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
26,966$148.56$4.01M235,724Sep 10, 2020Sep 12, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
11,132$147.68$1.64M262,690Sep 10, 2020Sep 12, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
4,856$146.85$713.1K273,822Sep 10, 2020Sep 12, 2020View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
3,086$32.40$100.0K233,327May 21, 2020May 26, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
100$141.58$14.2K230,241May 21, 2020May 26, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
39,0370May 21, 2020May 26, 2020View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
39,037$24.98$975.1K277,194May 21, 2020May 26, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
7,9161May 21, 2020May 26, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,377$140.99$194.1K230,341May 21, 2020May 26, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
3,08650,154May 21, 2020May 26, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
16,496$139.17$2.30M260,698May 21, 2020May 26, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
28,980$140.04$4.06M231,718May 21, 2020May 26, 2020View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
7,916$16.55$131.0K238,157May 21, 2020May 26, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
12,300$90.13$1.11M230,241Mar 4, 2020Mar 5, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
2,090$88.20$184.3K242,641Mar 3, 2020Mar 5, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
100$88.56$8.9K242,541Mar 3, 2020Mar 5, 2020View →
RGEN
REPLIGEN CORP
SALEGRANT
Stock grant
18,12818,128Feb 27, 2020Mar 2, 2020View →
RGEN
REPLIGEN CORP
PURCHASEGRANT
Stock grant
18,583244,731Feb 27, 2020Mar 2, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,594$86.10$137.2K226,148Feb 26, 2020Feb 27, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,881$86.86$163.4K227,742Feb 26, 2020Feb 27, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
10,2107,917Feb 25, 2020Feb 27, 2020View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
11,735$32.40$380.2K231,148Feb 25, 2020Feb 27, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
11,73553,240Feb 25, 2020Feb 27, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,624$90.22$146.5K219,413Feb 25, 2020Feb 27, 2020View →
RGEN
REPLIGEN CORP
PURCHASE
Chief Executive Officer
10,210$16.55$169.0K229,623Feb 25, 2020Feb 27, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
8,412$91.66$771.0K221,037Feb 25, 2020Feb 27, 2020View →
RGEN
REPLIGEN CORP
SALE
Chief Executive Officer
1,699$92.34$156.9K229,449Feb 25, 2020Feb 27, 2020View →
Other insiders · BLFS
Loading peer insiders…
About this filer
CIK 0001606030
ROLE
Director
PRIMARY
BLFS
COMPANIES
3
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001606030DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback